Eli Lilly and Co PE Ratio
Data as of October 02, 2026
PE Ratio (TTM)
40.60
Stock Price
$1149.85
EPS (TTM)
$29.80
Forward PE
26.25
How It's Calculated
40.60 = $1149.85 ÷ $29.80
What This Means
Eli Lilly and Co's PE ratio of 40.6 is significantly elevated, which often reflects very high growth expectations — or possible overvaluation.
About Eli Lilly and Co
Eli Lilly and Co (LLY) operates in the Pharmaceuticals sector, specifically in Pharmaceuticals. With a market capitalization of about $1.08T, it ranks as a mega-cap stock — one of the largest publicly traded companies.
Shares recently traded near $1149.85, within a 52-week range of $725.31 to $1292.65 (-11.0% from the high, +58.5% from the low). Beta of 0.43 indicates relatively lower volatility versus the market.
Trailing profit margin is about 33.5%, signaling a strong profit margin relative to many peers.
Understanding This Metric
The PE ratio is one of the most widely cited valuation multiples. For Eli Lilly and Co, it reflects how much investors pay today for each dollar of trailing earnings. High-growth Pharmaceuticals names often carry elevated PE ratios when the market prices in faster future profits, while mature companies with stable cash flows may trade at lower multiples even in the same sector.
Sector Comparison
Among Pharmaceuticals names on our S&P 100 coverage, Eli Lilly and Co's PE ratio of 40.60 can be compared with peers such as JNJ (29.97), MRK (112.48), PFE (38.01). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Pharmaceuticals stocks.
Key Takeaways
- LLY is grouped in the Pharmaceuticals sector for peer comparisons.
- Recent beta of 0.43 suggests lower-than-market price sensitivity.
- Trailing profit margin of 33.5% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for LLY.
Learn the full workflow
Compare PE with PB, PEG, EV/EBITDA, and market cap in one structured path.
Open the Stock Valuation hub →PEG Ratio
1.34
Sector
Pharmaceuticals
Other LLY Metrics
Frequently Asked Questions
What does LLY's PE ratio mean?
The PE ratio shows how much investors pay per dollar of trailing earnings for Eli Lilly and Co. A trailing PE of 40.60 means the market is pricing the stock at 40.60 times last twelve months' EPS — useful for comparing valuation across time and versus Pharmaceuticals peers, not as a buy/sell signal on its own.
Is 40.60 high or low vs sector peers?
Among Pharmaceuticals names in our S&P 100 coverage, peers such as BMY (13.54), JNJ (29.97), PFE (38.01) offer context. LLY's PE of 40.60 should be read with growth, margins, and balance-sheet risk — high PE can mean strong growth expectations; low PE can mean value or weaker outlook.
How often is this PE updated?
StockCalc refreshes LLY metrics on U.S. trading days; this page shows data as of October 02, 2026. PE moves with price daily and with EPS when companies report earnings.
Calculate the pe ratio for any stock with our free calculator.
Open PE Ratio Calculator →